Literature DB >> 25470439

Communication nonaccommodation in family conversations about end-of-life health decisions.

Allison M Scott1, John P Caughlin.   

Abstract

Furthering our understanding of how communication can improve end-of-life decision making requires a shift in focus from whether people talk to how people talk about end-of-life health decisions. This study used communication accommodation theory to examine the extent to which communication nonaccommodation distinguished more from less successful end-of-life conversations among family members. We analyzed elicited conversations about end-of-life health decisions from 121 older parent/adult child dyads using outside ratings of communication over- and underaccommodation and self-reported conversational outcomes. Results of multilevel linear modeling revealed that outside ratings of underaccommodation predicted self-reported and partner-reported uncertainty, and ratings of overaccommodation predicted self-reported decision-making efficacy and change in concordance accuracy. We discuss the methodological, theoretical, and practical implications of these findings.

Entities:  

Mesh:

Year:  2015        PMID: 25470439     DOI: 10.1080/10410236.2014.974128

Source DB:  PubMed          Journal:  Health Commun        ISSN: 1041-0236


  3 in total

1.  What Counts as "Good" Clinical Communication in the Coronavirus Disease 2019 Era and Beyond?: Ditching Checklists for Juggling Communication Goals.

Authors:  Allison M Scott; Lauren Jodi Van Scoy
Journal:  Chest       Date:  2020-05-27       Impact factor: 9.410

Review 2.  Understanding Elderspeak: An Evolutionary Concept Analysis.

Authors:  Clarissa A Shaw; Jean K Gordon
Journal:  Innov Aging       Date:  2021-07-03

Review 3.  Intergenerational Decision Making: The Role of Family Relationships in Medical Decision Making.

Authors:  Jody L Lin; Ellen A Lipstein; Eve Wittenberg; Djin Tay; Robert Lundstrom; Gari Lyn Lundstrom; Saadia Sediqzadah; Davene R Wright
Journal:  MDM Policy Pract       Date:  2021-10-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.